Taken together, these findings suggest that ZBM may regulate the development of pulmonary fibrosis partly through the PI3K/AKT/MDM2 and PI3K/AKT/GSK3B signaling pathways. The gene discussed is GSK3B; the disease is pulmonary fibrosis.